AKT1 increases the proliferation and survival of cancer cells and AKT inhibitors could control the progression, drug resistance, and immunosuppression of breast cancer (Hinz and Jücker, 2019; Jabbarzadeh Kaboli et al., 2020). This evidence concerns the gene AKT1 and cancer.